THTX
Income statement / Annual
Last year (2024), Theratechnologies Inc.'s total revenue was $85.87 M,
an increase of 5.02% from the previous year.
In 2024, Theratechnologies Inc.'s net income was -$8.31 M.
See Theratechnologies Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
11/30/2024 |
11/30/2023 |
11/30/2022 |
11/30/2021 |
11/30/2020 |
11/30/2019 |
11/30/2018 |
11/30/2017 |
11/30/2016 |
11/30/2015 |
| Operating Revenue |
$85.87 M |
$81.76 M |
$80.06 M |
$69.82 M |
$66.05 M |
$63.22 M |
$44.10 M |
$33.31 M |
$27.59 M |
$22.48 M |
| Cost of Revenue |
$20.45 M
|
$19.64 M
|
$26.28 M
|
$23.26 M
|
$26.90 M
|
$26.08 M
|
$12.97 M
|
$7.98 M
|
$4.96 M
|
$3.01 M
|
| Gross Profit |
$65.42 M
|
$62.13 M
|
$53.78 M
|
$46.56 M
|
$39.15 M
|
$37.14 M
|
$31.13 M
|
$25.33 M
|
$22.64 M
|
$19.47 M
|
| Gross Profit Ratio |
0.76
|
0.76
|
0.67
|
0.67
|
0.59
|
0.59
|
0.71
|
0.76
|
0.82
|
0.87
|
| Research and Development Expenses |
$16.97 M
|
$30.37 M
|
$36.94 M
|
$28.27 M
|
$18.02 M
|
$10.84 M
|
$7.78 M
|
$9.21 M
|
$5.18 M
|
$3.67 M
|
| General & Administrative Expenses |
$14.85 M
|
$15.62 M
|
$17.36 M
|
$14.62 M
|
$12.23 M
|
$8.33 M
|
$5.83 M
|
$4.52 M
|
$3.62 M
|
$3.03 M
|
| Selling & Marketing Expenses |
$25.42 M
|
$26.77 M
|
$39.39 M
|
$28.91 M
|
$26.86 M
|
$26.48 M
|
$21.69 M
|
$20.22 M
|
$9.42 M
|
$8.24 M
|
| Selling, General & Administrative Expenses |
$40.27 M
|
$42.39 M
|
$56.75 M
|
$43.53 M
|
$39.09 M
|
$34.81 M
|
$27.52 M
|
$24.74 M
|
$13.04 M
|
$11.28 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.49 M
|
$1.42 M
|
| Operating Expenses |
$57.24 M
|
$72.76 M
|
$93.69 M
|
$71.80 M
|
$57.11 M
|
$45.65 M
|
$34.54 M
|
$33.95 M
|
$19.71 M
|
$16.37 M
|
| Cost And Expenses |
$77.69 M
|
$92.39 M
|
$119.97 M
|
$95.06 M
|
$84.01 M
|
$71.73 M
|
$47.51 M
|
$41.93 M
|
$24.66 M
|
$19.38 M
|
| Interest Income |
$1.49 M
|
$0.00
|
$316.00 K
|
$195.00 K
|
$310.20 K
|
$1.10 M
|
$595.74 K
|
$262.36 K
|
$77.35 K
|
$30.79 K
|
| Interest Expense |
$10.42 M
|
$10.55 M
|
$6.50 M
|
$5.66 M
|
$5.60 M
|
$4.99 M
|
$2.53 M
|
$1.10 M
|
$1.47 M
|
$1.88 M
|
| Depreciation & Amortization |
$2.76 M
|
$3.32 M
|
$12.47 M
|
$8.75 M
|
$8.52 M
|
$7.50 M
|
$4.23 M
|
$1.55 M
|
$1.57 M
|
$1.43 M
|
| EBITDA |
$6.88 M |
-$8.91 M |
-$27.83 M |
-$17.25 M |
-$8.77 M |
-$11.00 K |
$788.00 K |
-$11.72 M |
$3.79 M |
$4.90 M |
| EBITDA Ratio |
0.08
|
-0.11
|
-0.35
|
-0.25
|
-0.13
|
-0
|
0.02
|
-0.35
|
0.14
|
0.22
|
| Operating Income Ratio |
0.1
|
-0.13
|
-0.5
|
-0.36
|
-0.27
|
-0.13
|
-0.08
|
-0.26
|
0.11
|
0.14
|
| Total Other Income/Expenses Net |
-$14.48 M
|
-$12.91 M
|
-$6.89 M
|
-$6.43 M
|
-$4.69 M
|
-$3.98 M
|
-$2.41 M
|
-$5.71 M
|
-$2.15 M
|
-$1.50 M
|
| Income Before Tax |
-$6.30 M
|
-$23.54 M
|
-$46.79 M
|
-$31.66 M
|
-$22.65 M
|
-$12.50 M
|
-$5.97 M
|
-$14.34 M
|
$780.77 K
|
$1.60 M
|
| Income Before Tax Ratio |
-0.07
|
-0.29
|
-0.58
|
-0.45
|
-0.34
|
-0.2
|
-0.14
|
-0.43
|
0.03
|
0.07
|
| Income Tax Expense |
$2.01 M
|
$421.00 K
|
$443.00 K
|
$63.00 K
|
$16.00 K
|
$0.00
|
-$1.27 M
|
$0.00
|
$475.61 K
|
$425.54 K
|
| Net Income |
-$8.31 M
|
-$23.96 M
|
-$47.24 M
|
-$31.73 M
|
-$22.67 M
|
-$12.50 M
|
-$4.70 M
|
-$14.34 M
|
$305.16 K
|
$1.17 M
|
| Net Income Ratio |
-0.1
|
-0.29
|
-0.59
|
-0.45
|
-0.34
|
-0.2
|
-0.11
|
-0.43
|
0.01
|
0.05
|
| EPS |
-0.17 |
-0.33 |
-0.5 |
-0.34 |
-0.29 |
-0.23 |
-0.0596 |
-0.2 |
0.0074 |
0.0224 |
| EPS Diluted |
-0.17 |
-0.33 |
-0.5 |
-0.34 |
-0.29 |
-0.23 |
-0.0596 |
-0.2 |
0.0074 |
0.015 |
| Weighted Average Shares Out |
$49.36 M
|
$73.08 M
|
$95.25 M
|
$92.35 M
|
$76.99 M
|
$76.93 M
|
$75.94 M
|
$73.47 M
|
$65.81 M
|
$62.49 M
|
| Weighted Average Shares Out Diluted |
$49.36 M
|
$73.08 M
|
$95.25 M
|
$92.35 M
|
$76.99 M
|
$76.93 M
|
$75.94 M
|
$73.47 M
|
$66.60 M
|
$63.17 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
